Zhejiang Yongtai Pharma

Zhejiang Yongtai Pharma is a vertically integrated pharmaceutical company based in China, operating as a key subsidiary of Zhejiang Yongtai Technology. The company specializes in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms, with a strong emphasis on small molecule chemistry. Its product portfolio spans several major therapeutic areas, including cardiovascular health, diabetes management, and central nervous system disorders. With multiple GMP-certified facilities and successful regulatory inspections from the US FDA and EU authorities, Zhejiang Yongtai Pharma serves as both a generic drug manufacturer and a CDMO partner for global pharmaceutical firms. The company leverages its parent organization's expertise in fluorination technology to produce complex intermediates and high-quality pharmaceutical products for international markets.